☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
NeuroBo Pharmaceuticals
Neurobo Pharmaceuticals Reports First Patient Dosing in P-I Study of DA-1726 to Treat Obesity
June 27, 2024
NeuroBo Pharmaceuticals Reports IND Submission to the US FDA for Conducting P-I Study of DA-1726 to Treat Obesity
January 1, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.